Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia.

Sugawara N, Yasui-Furukori N, Sato Y, Kishida I, Yamashita H, Saito M, Furukori H, Nakagami T, Hatakeyama M, Kaneko S.

Ann Gen Psychiatry. 2011 Sep 12;10:21. doi: 10.1186/1744-859X-10-21.

PMID:
21910863
[PubMed]
Free PMC Article
2.

Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia.

Rezaei O, Khodaie-Ardakani MR, Mandegar MH, Dogmehchi E, Goodarzynejad H.

Int J Psychiatry Med. 2009;39(4):451-62.

PMID:
20391865
[PubMed - indexed for MEDLINE]
3.

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group.

Int J Cardiol. 2007 Apr 25;117(2):204-10. Epub 2006 Jul 18.

PMID:
16854482
[PubMed - indexed for MEDLINE]
4.

Prevalence of metabolic syndrome among inpatients with schizophrenia.

Boke O, Aker S, Sarisoy G, Saricicek EB, Sahin AR.

Int J Psychiatry Med. 2008;38(1):103-12.

PMID:
18624022
[PubMed - indexed for MEDLINE]
5.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
[PubMed - indexed for MEDLINE]
6.

Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population.

Bener A, Mohammad AG, Ismail AN, Zirie M, Abdullatef WK, Al-Hamaq AO.

Bosn J Basic Med Sci. 2010 Aug;10(3):210-7.

PMID:
20846127
[PubMed - indexed for MEDLINE]
7.

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.

Athyros VG, Ganotakis ES, Tziomalos K, Papageorgiou AA, Anagnostis P, Griva T, Kargiotis K, Mitsiou EK, Karagiannis A, Mikhailidis DP.

Curr Med Res Opin. 2010 Mar;26(3):713-9. doi: 10.1185/03007991003590597.

PMID:
20078335
[PubMed - indexed for MEDLINE]
8.

Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population.

Lee NY, Kim SH, Cho B, Lee YJ, Chang JS, Kang UG, Kim YS, Ahn YM.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 1;34(7):1243-9. doi: 10.1016/j.pnpbp.2010.06.029. Epub 2010 Jul 3.

PMID:
20599461
[PubMed - indexed for MEDLINE]
9.

The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.

Athyros VG, Bouloukos VI, Pehlivanidis AN, Papageorgiou AA, Dionysopoulou SG, Symeonidis AN, Petridis DI, Kapousouzi MI, Satsoglou EA, Mikhailidis DP; MetS-Greece Collaborative Group.

Diabetes Obes Metab. 2005 Jul;7(4):397-405.

PMID:
15955126
[PubMed - indexed for MEDLINE]
10.

Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.

Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG.

Hum Reprod. 2008 Oct;23(10):2352-8. doi: 10.1093/humrep/den263. Epub 2008 Jul 16.

PMID:
18635531
[PubMed - indexed for MEDLINE]
Free Article
11.

Prevalence of metabolic syndrome and factors associated with its components in Chinese adults.

Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A.

Metabolism. 2009 Aug;58(8):1102-8. doi: 10.1016/j.metabol.2009.04.008. Epub 2009 Jun 18.

PMID:
19481771
[PubMed - indexed for MEDLINE]
12.

[Survey of obesity and underweight among inpatients with schizophrenia in psychiatric hospitals throughout Japan].

Inamura Y, Sagae T, Kushida O, Nakamachi K, Murayama N.

Seishin Shinkeigaku Zasshi. 2013;115(1):10-21. Japanese.

PMID:
23691790
[PubMed - indexed for MEDLINE]
13.
14.

Effect of age and disease on bone mass in Japanese patients with schizophrenia.

Sugawara N, Yasui-Furukori N, Umeda T, Tsuchimine S, Fujii A, Sato Y, Saito M, Furukori H, Danjo K, Matsuzaka M, Takahashi I, Kaneko S.

Ann Gen Psychiatry. 2012 Feb 20;11:5. doi: 10.1186/1744-859X-11-5.

PMID:
22348381
[PubMed]
Free PMC Article
15.

Prevalence of metabolic syndrome among patients with schizophrenia in Japan.

Sugawara N, Yasui-Furukori N, Sato Y, Umeda T, Kishida I, Yamashita H, Saito M, Furukori H, Nakagami T, Hatakeyama M, Nakaji S, Kaneko S.

Schizophr Res. 2010 Nov;123(2-3):244-50. doi: 10.1016/j.schres.2010.08.030. Epub 2010 Sep 17.

PMID:
20850274
[PubMed - indexed for MEDLINE]
16.

Sociodemographic risk factors associated with metabolic syndrome in a Mediterranean population.

Buckland G, Salas-Salvadó J, Roure E, Bulló M, Serra-Majem L.

Public Health Nutr. 2008 Dec;11(12):1372-8. doi: 10.1017/S1368980008003492. Epub 2008 Aug 15.

PMID:
18702840
[PubMed - indexed for MEDLINE]
17.
18.

The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.

Nilsson PM, Engström G, Hedblad B.

Diabet Med. 2007 May;24(5):464-72. Epub 2007 Mar 22.

PMID:
17381496
[PubMed - indexed for MEDLINE]
19.

Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.

Koutsovasilis A, Protopsaltis J, Triposkiadis F, Kokkoris S, Milionis HJ, Zairis MN, Skoularigis J, Koukoulis G, Korantzopoulos P, Melidonis A, Foussas SG.

Intern Med. 2009;48(4):179-87. Epub 2009 Feb 16.

PMID:
19218766
[PubMed - indexed for MEDLINE]
Free Article
20.

Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders.

Tirupati S, Chua LE.

Australas Psychiatry. 2007 Dec;15(6):470-3.

PMID:
17999257
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk